Rocket Lab’s (NASDAQ:RKLB) Q2 CY2026: Beats On Revenue, Provides Optimistic Revenue Guidance for Next Quarter
Rocket Lab (NASDAQ:RKLB) reported Q2 CY2026 revenue of $234.1 million, up 62% year on year and 0.9% above estimates, with GAAP EPS loss of $0.08 per share. Management guided next-quarter revenue to $257.5 million at the midpoint. Analysts expect full-year EPS to improve from -$0.28 to -$0.13; shares fell 1.8% to $78.87.
How this was made
The 30-second read
Why it matters
Traders can reassess near-term revenue trajectory and expectations for demand, but should also weigh that GAAP losses persist and operating margin remains negative, which can limit sustained upside.
Market read
Q2 revenue beat plus above-consensus next-quarter revenue guidance is the primary catalyst, partially offset by continued negative EPS and negative operating margin.
What to watch
The guidance beat is framed as optimistic, but the article also notes EPS missed consensus and that operating margin is still deeply negative, which can cap multiple expansion.
Background
Rocket Lab is a space launch provider focused on small satellites, and the article frames its Q2 performance around revenue growth, operating leverage, and EPS trajectory.
Ticker impact
Rocket Lab reported Q2 CY2026 revenue of $234.1M, up 62% YoY, and guided next-quarter revenue to $257.5M midpoint.
Bias toward upside or reduced downside risk into the next quarter, with volatility possible given EPS remains negative and the article notes shares fell 1.8% immediately after results.
The article provides concrete Q2 revenue and next-quarter revenue guidance versus expectations, but also highlights negative GAAP EPS and an immediate post-results dip, implying the market may have weighed profitability concerns.
Market effects
Reinforces demand signals for small-satellite launch services, but profitability remains a key overhang for space/defense growth names.
Limited direct regional spillover; primarily affects US-listed aerospace/defense growth sentiment.
Modest global relevance, as the disclosure is company-specific rather than a sector-wide policy or procurement shift.
Counterpoint
Revenue strength may not translate into improving profitability soon, since operating margins and GAAP EPS remain negative and the article flags the need for an inflection point.
Key entities
- companyRocket Lab
Reported Q2 CY2026 revenue beat and provided next-quarter revenue guidance; GAAP EPS remains negative.
